Belgian Body Bolsters Awareness Of Biosimilars

Belgian medicines agency AFMPS has launched a public information campaign to educate patients on biologics and to encourage the uptake of biosimilars.

Nurse
The AFMPS Campaign Will Educate Both Doctors And Patients • Source: Shutterstock

A public information campaign “to enlighten patients about biologic medicines and to encourage the prescription of biosimilars” has been launched by Belgian medicines agency AFMPS, in conjunction with local health insurer INAMI.

Explaining that the campaign was aimed at “informing patients about biologic medicines, which widen the field of possibilities for treating...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Regulation

More from Policy & Regulation

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Policy&Regulation-Free: Article with different widgets

    Emerging CRISPR innovations, shifting regulatory landscapes, and rising partnerships are accelerating a paradigm shift in biotech pipelines

  • Overseas API Manufacturing Identified As Key Vulnerability In US Supply Chain

    After US President Joe Biden launched a review of the country’s API supply chain, the task force has reported back with key vulnerabilities that contribute to drug shortages and supply risks during a global public health emergency. According to the report, the lack of geographic diversity and dependence on foreign nations and anti-competitive actions by foreign nations are key areas of concern.